[
{
"numtree":"1.0.0.0",
"id":"1",
"nametree":"Authors and legal information",
"tocnametree":"Authors and legal information",
"htmlpage":"ENAS5268_1.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.0.0.0",
"id":"2",
"nametree":"Prevention of CINV",
"tocnametree":"Prevention of CINV",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.1.0.0",
"id":"3",
"nametree":"Levels of emetogenicity",
"tocnametree":"Levels of emetogenicity",
"htmlpage":"ENAS5268_2.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.2.0.0",
"id":"4",
"nametree":"Induced by highly emetogenic ChT",
"tocnametree":"Induced by highly emetogenic ChT",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.2.1.0",
"id":"5",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_2.2.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.2.2.0",
"id":"6",
"nametree":"Cisplatin-treated patients",
"tocnametree":"Cisplatin-treated patients",
"htmlpage":"ENAS5268_2.2.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.2.3.0",
"id":"7",
"nametree":"AC-treated female pts. with BC",
"tocnametree":"AC-treated female pts. with breast cancer",
"htmlpage":"ENAS5268_2.2.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.2.4.0",
"id":"8",
"nametree":"Are there differences between the NK1 RAs?",
"tocnametree":"Are there differences between the NK1 RAs?",
"htmlpage":"ENAS5268_2.2.4.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.2.5.0",
"id":"9",
"nametree":"Other highly emetogenic ChT",
"tocnametree":"Other highly emetogenic ChT",
"htmlpage":"ENAS5268_2.2.5.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.3.0.0",
"id":"10",
"nametree":"Dose, schedule, route & safety of antiemetics",
"tocnametree":"Dose, schedule, route & safety of antieme.",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.3.1.0",
"id":"11",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_2.3.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.3.2.0",
"id":"12",
"nametree":"Doses of (5-HT)3 receptor antagonists",
"tocnametree":"Doses of (5-HT)3 receptor antagonists",
"htmlpage":"ENAS5268_2.3.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.3.3.0",
"id":"13",
"nametree":"Doses of corticosteroids",
"tocnametree":"Doses of corticosteroids",
"htmlpage":"ENAS5268_2.3.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.3.4.0",
"id":"14",
"nametree":"Doses of NK1 receptor antagonists",
"tocnametree":"Doses of NK1 receptor antagonists",
"htmlpage":"ENAS5268_2.3.4.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.3.5.0",
"id":"15",
"nametree":"Olanzapine",
"tocnametree":"Olanzapine",
"htmlpage":"ENAS5268_2.3.5.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.4.0.0",
"id":"16",
"nametree":"Induced by MEC",
"tocnametree":"Induced by MEC",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.1.0",
"id":"17",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_2.4.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.4.2.0",
"id":"18",
"nametree":"Carboplatin",
"tocnametree":"Carboplatin",
"htmlpage":"ENAS5268_2.4.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.4.3.0",
"id":"19",
"nametree":"Oxaliplatin",
"tocnametree":"Oxaliplatin",
"htmlpage":"ENAS5268_2.4.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.5.0.0",
"id":"20",
"nametree":"Induced by multiple-day cisplatin ChT",
"tocnametree":"Induced by multiple-day cisplatin ChT",
"htmlpage":"ENAS5268_2.5.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.6.0.0",
"id":"21",
"nametree":"Prev. by ChT with low & min. emetogenic pot.",
"tocnametree":"Induced by low & min. emetogenic pot.",
"htmlpage":"ENAS5268_2.6.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.7.0.0",
"id":"22",
"nametree":"Breakthr. ChT-induced & refrac. emesis",
"tocnametree":"Breakthr. ChT-induced & refrac. emesis",
"htmlpage":"ENAS5268_2.7.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.8.0.0",
"id":"23",
"nametree":"Prev. of anticipatory nausea and vomiting",
"tocnametree":"Prev. of anticipatory nausea and vomiting",
"htmlpage":"ENAS5268_2.8.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.9.0.0",
"id":"24",
"nametree":"Induced by high-dose chemotherapy",
"tocnametree":"Induced by high-dose chemotherapy",
"htmlpage":"ENAS5268_2.9.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.0.0.0",
"id":"25",
"nametree":"Prevention of RINV",
"tocnametree":"Prevention of RINV",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.1.0.0",
"id":"26",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_3.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.2.0.0",
"id":"27",
"nametree":"Radiotherapy emetic risk levels",
"tocnametree":"Radiotherapy emetic risk levels",
"htmlpage":"ENAS5268_3.2.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.3.0.0",
"id":"28",
"nametree":"Risk classification",
"tocnametree":"Risk classification",
"htmlpage":"ENAS5268_3.3.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.4.0.0",
"id":"29",
"nametree":"Antiemetic treatment options",
"tocnametree":"Antiemetic treatment options",
"htmlpage":"ENAS5268_3.4.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.5.0.0",
"id":"30",
"nametree":"Concurrent chemoradiotherapy",
"tocnametree":"Concurrent chemoradiotherapy",
"htmlpage":"ENAS5268_3.5.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.0.0.0",
"id":"31",
"nametree":"Acute CINV in children",
"tocnametree":"Acute CINV in children",
"htmlpage":"ENAS5268_4.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"5.0.0.0",
"id":"32",
"nametree":"Antiemetics in advanced cancer",
"tocnametree":"Antiemetics in advanced cancer",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.1.0.0",
"id":"33",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_5.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"5.2.0.0",
"id":"34",
"nametree":"NV in malignant bowel obstruction",
"tocnametree":"NV in malignant bowel obstruction",
"htmlpage":"ENAS5268_5.2.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"5.3.0.0",
"id":"35",
"nametree":"Opioid-induced nausea and vomiting",
"tocnametree":"Opioid-induced nausea and vomiting",
"htmlpage":"ENAS5268_5.3.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.0.0.0",
"id":"36",
"nametree":"Summary of recommendations",
"tocnametree":"Summary of recommendations",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.1.0.0",
"id":"37",
"nametree":"Prevention of CINV",
"tocnametree":"Prevention of CINV",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.1.1.0",
"id":"38",
"nametree":"Levels of emetogenicity",
"tocnametree":"Levels of emetogenicity",
"htmlpage":"ENAS5268_6.1.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.2.0",
"id":"39",
"nametree":"Induced by highly emetogenic ChT",
"tocnametree":"Induced by highly emetogenic ChT",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.1.2.1",
"id":"40",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_6.1.2.1",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.2.2",
"id":"41",
"nametree":"Cisplatin-treated patients",
"tocnametree":"Cisplatin-treated patients",
"htmlpage":"ENAS5268_6.1.2.2",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.2.3",
"id":"42",
"nametree":"AC-treated female pts. with BC",
"tocnametree":"AC-treated female pts. with breast cancer",
"htmlpage":"ENAS5268_6.1.2.3",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.2.4",
"id":"43",
"nametree":"Other highly emetogenic ChT",
"tocnametree":"Other highly emetogenic ChT",
"htmlpage":"ENAS5268_6.1.2.4",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.3.0",
"id":"44",
"nametree":"Dose, schedule, route & safety of antiemetics",
"tocnametree":"Dose, schedule, route & safety of antiemetics",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.1.3.1",
"id":"45",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_6.1.3.1",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.3.2",
"id":"46",
"nametree":"Olanzapine",
"tocnametree":"Olanzapine",
"htmlpage":"ENAS5268_6.1.3.2",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.4.0",
"id":"47",
"nametree":"Induced by MEC",
"tocnametree":"Induced by MEC",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.1.4.1",
"id":"48",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_6.1.4.1",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.4.2",
"id":"49",
"nametree":"Carboplatin",
"tocnametree":"Carboplatin",
"htmlpage":"ENAS5268_6.1.4.2",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.4.3",
"id":"50",
"nametree":"Oxaliplatin",
"tocnametree":"Oxaliplatin",
"htmlpage":"ENAS5268_6.1.4.3",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.5.0",
"id":"51",
"nametree":"Induced by multiple-day cisplatin ChT",
"tocnametree":"Induced by multiple-day cisplatin",
"htmlpage":"ENAS5268_6.1.5.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.6.0",
"id":"52",
"nametree":"Induced by ChT with low & min. emetogenic pot.",
"tocnametree":"Induced by low & min. emetogenic pot.",
"htmlpage":"ENAS5268_6.1.6.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.7.0",
"id":"53",
"nametree":"Breakthr. ChT-induced & refrac. emesis",
"tocnametree":"Breakthr. ChT-induced & refrac. emesis",
"htmlpage":"ENAS5268_6.1.7.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.8.0",
"id":"54",
"nametree":"Prev. of anticipatory nausea and vomiting",
"tocnametree":"Prev. of anticipatory nausea and vomiting",
"htmlpage":"ENAS5268_6.1.8.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.1.9.0",
"id":"55",
"nametree":"Induced by high-dose chemotherapy",
"tocnametree":"Induced by high-dose chemotherapy",
"htmlpage":"ENAS5268_6.1.9.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.2.0.0",
"id":"56",
"nametree":"Prevention of RINV",
"tocnametree":"Prevention of RINV",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.2.1.0",
"id":"57",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_6.2.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.2.2.0",
"id":"58",
"nametree":"Risk classification",
"tocnametree":"Risk classification",
"htmlpage":"ENAS5268_6.2.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.2.3.0",
"id":"59",
"nametree":"Antiemetic treatment options",
"tocnametree":"Antiemetic treatment options",
"htmlpage":"ENAS5268_6.2.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.2.4.0",
"id":"60",
"nametree":"Concurrent chemoradiotherapy",
"tocnametree":"Concurrent chemoradiotherapy",
"htmlpage":"ENAS5268_6.2.4.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.3.0.0",
"id":"61",
"nametree":"Acute CINV in children",
"tocnametree":"Acute CINV in children",
"htmlpage":"ENAS5268_6.3.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.4.0.0",
"id":"62",
"nametree":"Antiemetics in advanced cancer",
"tocnametree":"Antiemetics in advanced cancer",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.4.1.0",
"id":"63",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5268_6.4.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.4.2.0",
"id":"64",
"nametree":"NV in malignant bowel obstruction",
"tocnametree":"NV in malignant bowel obstruction",
"htmlpage":"ENAS5268_6.4.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.4.3.0",
"id":"65",
"nametree":"Opioid-induced nausea and vomiting",
"tocnametree":"Opioid-induced nausea and vomiting",
"htmlpage":"ENAS5268_6.4.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.0.0.0",
"id":"66",
"nametree":"Glossary",
"tocnametree":"Glossary",
"htmlpage":"ENAS5268_7.0.0.0",
"haspdf":false,
"emailContent":true
}
]